Kezar Life Sciences Inc.

NASDAQ: KZR · Real-Time Price · USD
3.97
-0.01 (-0.25%)
At close: Aug 15, 2025, 3:59 PM
3.97
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Kezar Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-83.74M -101.87M -68.24M -54.63M
Depreciation & Amortization
1.04M 1.07M 1.02M 1.51M
Stock-Based Compensation
13.01M 18.14M 14.01M 7.6M
Other Working Capital
1.85M -1.64M -6.27M 9K
Other Non-Cash Items
-3.23M -3.68M -1.18M 91K
Deferred Income Tax
n/a n/a n/a 1.77M
Change in Working Capital
-1.3M 4.71M -4.46M 1.23M
Operating Cash Flow
-74.21M -81.64M -58.85M -42.44M
Capital Expenditures
-29K -1.81M -1.58M -316K
Cash Acquisitions
n/a n/a 89.81K 28.13K
Purchase of Investments
-91.34M -180.4M -332.2M -156.38M
Sales Maturities Of Investments
171.79M 258.25M 242.39M 128.25M
Other Investing Acitivies
n/a 5K -89.81K -28.13K
Investing Cash Flow
80.43M 76.05M -91.39M -28.44M
Debt Repayment
n/a n/a n/a 9.53M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.32M 2.08M
Financial Cash Flow
103K 638K 127.86M 112.58M
Net Cash Flow
6.26M -4.96M -22.43M 41.65M
Free Cash Flow
-74.24M -83.45M -60.42M -42.75M